Hing C. Wong

9.4k total citations · 2 hit papers
124 papers, 6.2k citations indexed

About

Hing C. Wong is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Hing C. Wong has authored 124 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Immunology, 57 papers in Oncology and 33 papers in Molecular Biology. Recurrent topics in Hing C. Wong's work include Immune Cell Function and Interaction (53 papers), CAR-T cell therapy research (42 papers) and T-cell and B-cell Immunology (24 papers). Hing C. Wong is often cited by papers focused on Immune Cell Function and Interaction (53 papers), CAR-T cell therapy research (42 papers) and T-cell and B-cell Immunology (24 papers). Hing C. Wong collaborates with scholars based in United States, Italy and China. Hing C. Wong's co-authors include Emily K. Jeng, Peter R. Rhode, N. Rama Krishna, H.R. Whiteley, H E Schnepf, M. Lamar Seibenhener, Marie W. Wooten, Jeganathan Ramesh Babu, Thangiah Geetha and Sui‐Yuan Chang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Hing C. Wong

120 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sequestosome 1/p62 Is a Polyubiquitin Chain Binding Protein Involved in Ubiquitin Proteasome Degradation

2004 572 citations Hing C. Wong et al. profile →
Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery

2018 542 citations Li Tang, Yiran Zheng et al. Nature Biotechnology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hing C. Wong United States	41	2.8k	2.2k	2.0k	661	650	124	6.2k
Hua Liang China	29	4.1k 1.5×	2.2k 1.0×	4.1k 2.1×	510 0.8×	438 0.7×	79	7.9k
Hugues Lortat‐Jacob France	53	2.1k 0.8×	3.8k 1.7×	1.3k 0.7×	287 0.4×	773 1.2×	146	8.1k
Jean‐Jacques Fournié France	57	6.4k 2.3×	2.1k 1.0×	2.5k 1.3×	688 1.0×	976 1.5×	216	10.3k
Richard P. Junghans United States	41	2.4k 0.9×	2.0k 0.9×	2.4k 1.2×	559 0.8×	293 0.5×	99	5.7k
Michael Bachmann Germany	55	3.1k 1.1×	3.9k 1.8×	4.0k 2.0×	1.5k 2.2×	363 0.6×	315	10.2k
Fabiola Ciccosanti Italy	28	2.0k 0.7×	1.8k 0.8×	1.2k 0.6×	527 0.8×	1.0k 1.6×	61	5.0k
Patrice N. Marche France	42	2.2k 0.8×	1.9k 0.9×	470 0.2×	536 0.8×	762 1.2×	227	5.7k
Marco Rusnati Italy	55	1.7k 0.6×	5.8k 2.6×	996 0.5×	278 0.4×	534 0.8×	174	9.0k
Michael J. Kruhlak United States	53	1.9k 0.7×	6.1k 2.7×	2.2k 1.1×	204 0.3×	843 1.3×	118	9.1k

Countries citing papers authored by Hing C. Wong

Since Specialization

Citations

This map shows the geographic impact of Hing C. Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hing C. Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hing C. Wong more than expected).

Fields of papers citing papers by Hing C. Wong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hing C. Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hing C. Wong. The network helps show where Hing C. Wong may publish in the future.

Co-authorship network of co-authors of Hing C. Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Hing C. Wong. A scholar is included among the top collaborators of Hing C. Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hing C. Wong. Hing C. Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fantini, Massimo, Justin M. David, Hing C. Wong, et al.. (2019). An IL-15 Superagonist, ALT-803, Enhances Antibody-Dependent Cell-Mediated Cytotoxicity Elicited by the Monoclonal Antibody NEO-201 Against Human Carcinoma Cells. Cancer Biotherapy and Radiopharmaceuticals. 34(3). 147–159. 20 indexed citations

Johnson, Christopher, Brian Riesenberg, Samantha Suriano, et al.. (2018). Enhanced Lymphodepletion Is Insufficient to Replace Exogenous IL2 or IL15 Therapy in Augmenting the Efficacy of Adoptively Transferred Effector CD8+ T Cells. Cancer Research. 78(11). 3067–3074. 7 indexed citations

Margolin, Kim, Chihiro Morishima, Vamsidhar Velcheti, et al.. (2018). Phase I Trial of ALT-803, A Novel Recombinant IL15 Complex, in Patients with Advanced Solid Tumors. Clinical Cancer Research. 24(22). 5552–5561. 146 indexed citations

Tang, Li, Yiran Zheng, Mariane B. Melo, et al.. (2018). Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery. Nature Biotechnology. 36(8). 707–716. 542 indexed citations breakdown →

Garg, Tarun K., Katie Stone, Amy D Greenway, et al.. (2017). The IL15 Superagonist Complex ALT-803 Potently Enhances the Proliferative Capacity and Activity of in Vitro Expanded Natural Killer Cells. Blood. 130. 5452–5452. 1 indexed citations

Chu, Yaya, Nang Kham Su, Sarah Alter, et al.. (2017). Therapeutic Effects of a Novel Fusion of ALT-803, an IL-15 Superagonist, with 4 Single-Chains of Anti-CD20 Antibody (2B8T2M) in Combination with Expanded Natural Killer Cells Against Rituximab Sensitive and Resistant Burkitt Lymphoma (BL). Blood. 130. 3587–3587. 1 indexed citations

Hernandez, Reinier, Christopher G. England, Yunan Yang, et al.. (2017). ImmunoPET imaging of tissue factor expression in pancreatic cancer with 89Zr-Df-ALT-836. Journal of Controlled Release. 264. 160–168. 17 indexed citations

Luo, Haiming, Christopher G. England, Sixiang Shi, et al.. (2016). Dual Targeting of Tissue Factor and CD105 for Preclinical PET Imaging of Pancreatic Cancer. Clinical Cancer Research. 22(15). 3821–3830. 30 indexed citations

Church, Candice D., Jian Zheng, Christina Ochsenbauer, et al.. (2015). In Vivo Activation of Human NK Cells by Treatment with an Interleukin-15 Superagonist Potently Inhibits Acute In Vivo HIV-1 Infection in Humanized Mice. Journal of Virology. 89(12). 6264–6274. 74 indexed citations

10.

Rhode, Peter R., Jack O. Egan, Wenxin Xu, et al.. (2015). Comparison of the Superagonist Complex, ALT-803, to IL15 as Cancer Immunotherapeutics in Animal Models. Cancer Immunology Research. 4(1). 49–60. 170 indexed citations

11.

Xu, Wenxin, Monica Jones, Bai Liu, et al.. (2013). Efficacy and Mechanism-of-Action of a Novel Superagonist Interleukin-15: Interleukin-15 Receptor αSu/Fc Fusion Complex in Syngeneic Murine Models of Multiple Myeloma. Cancer Research. 73(10). 3075–3086. 157 indexed citations

12.

Hong, Hao, Yin Zhang, Tapas R. Nayak, et al.. (2012). Immuno-PET of Tissue Factor in Pancreatic Cancer. Journal of Nuclear Medicine. 53(11). 1748–1754. 45 indexed citations

13.

Zhu, Xiaoyun, Warren D. Marcus, Wenxin Xu, et al.. (2009). Novel Human Interleukin-15 Agonists. The Journal of Immunology. 183(6). 3598–3607. 123 indexed citations

14.

You, Lijing, Kaiping Han, Hyung‐il Lee, et al.. (2007). Peptide-loading enhancement for antigen presenting cells (93.6). The Journal of Immunology. 178(1_Supplement). S167–S167. 1 indexed citations

15.

Zhu, Xiaoyun, Shari A. Price‐Schiavi, Hyung‐il Lee, et al.. (2006). Visualization of p53264–272/HLA-A*0201 Complexes Naturally Presented on Tumor Cell Surface by a Multimeric Soluble Single-Chain T Cell Receptor. The Journal of Immunology. 176(5). 3223–3232. 24 indexed citations

16.

Price‐Schiavi, Shari A., Xiaoyun Zhu, Pierre‐André Chavaillaz, et al.. (2005). In Vitro and In Vivo Characterization of a Novel Antibody-Like Single-Chain TCR Human IgG1 Fusion Protein. The Journal of Immunology. 174(7). 4381–4388. 26 indexed citations

17.

Price‐Schiavi, Shari A., et al.. (2004). A novel soluble single-chain T-cell receptor IgG1 fusion protein retains MHC restricted peptide specific antigen binding and exhibits anti-tumor effects in vivo.. Cancer Research. 64. 503–503. 1 indexed citations

18.

Morrow, David A., Rafael F. Sequeira, Tim Henry, et al.. (2004). 861-3 A phase I open-label dose escalation trial of a monoclonal antibody against tissue factor (sunol cH36) in stable coronary artery disease: Results of the PROXIMATE-TIMI 27 trial. Journal of the American College of Cardiology. 43(5). A303–A303. 1 indexed citations

19.

Tal, Rony, Vaughan Wittman, Pierre‐André Chavaillaz, et al.. (1998). Improving the binding affinity of an antibody using molecular modeling and site‐directed mutagenesis. Protein Science. 7(8). 1671–1680. 2 indexed citations

20.

Ngeow, Yun Fong, et al.. (1991). Hepatitis B Infection Among Chinese STD Patients in Kuala Lumpur, Malaysia. Sexually Transmitted Diseases. 18(2). 84–88. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact